JP2023553247A5 - - Google Patents
Info
- Publication number
- JP2023553247A5 JP2023553247A5 JP2023521107A JP2023521107A JP2023553247A5 JP 2023553247 A5 JP2023553247 A5 JP 2023553247A5 JP 2023521107 A JP2023521107 A JP 2023521107A JP 2023521107 A JP2023521107 A JP 2023521107A JP 2023553247 A5 JP2023553247 A5 JP 2023553247A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063087427P | 2020-10-05 | 2020-10-05 | |
| US63/087,427 | 2020-10-05 | ||
| PCT/US2021/053503 WO2022076364A1 (en) | 2020-10-05 | 2021-10-05 | Compositions and methods for cancer diagnosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023553247A JP2023553247A (ja) | 2023-12-21 |
| JPWO2022076364A5 JPWO2022076364A5 (https=) | 2024-10-15 |
| JP2023553247A5 true JP2023553247A5 (https=) | 2024-10-15 |
Family
ID=81126198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521107A Pending JP2023553247A (ja) | 2020-10-05 | 2021-10-05 | がん診断のための組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250277793A1 (https=) |
| EP (1) | EP4225365A4 (https=) |
| JP (1) | JP2023553247A (https=) |
| KR (1) | KR20230155419A (https=) |
| CN (1) | CN117120086A (https=) |
| AU (1) | AU2021357695A1 (https=) |
| CA (1) | CA3197304A1 (https=) |
| IL (1) | IL301783A (https=) |
| MX (1) | MX2023003771A (https=) |
| WO (1) | WO2022076364A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL315829A (en) * | 2022-04-04 | 2024-11-01 | Aoa Dx | Mass spectrometry methods for cancer diagnosis |
| WO2025096441A1 (en) * | 2023-10-30 | 2025-05-08 | The Board Of Trustees Of The Leland Stanford Junior University | Ganglioside gm2 as a target for cancer immunotherapy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2329897A1 (en) * | 1998-04-28 | 1999-11-04 | Galenica Pharmaceuticals, Inc. | Polysaccharide-antigen conjugates |
| ES2904533T3 (es) * | 2013-12-06 | 2022-04-05 | Aoa Dx | Compuesto antigangliósido para dirigirlo contra el cáncer y generar anticuerpos |
| WO2017048823A1 (en) * | 2015-09-18 | 2017-03-23 | Mackay Memorial Hospital Of Taiwan Presbyterian Church And Mackay Memorial Social Work Foundation | Immunogenic glycopeptide compounds, pharmaceutical compositions and uses thereof |
| WO2018112669A1 (en) * | 2016-12-23 | 2018-06-28 | Realist Pharma, Inc. | Ganglioside carbohydrate structures and uses thereof |
-
2021
- 2021-10-05 WO PCT/US2021/053503 patent/WO2022076364A1/en not_active Ceased
- 2021-10-05 IL IL301783A patent/IL301783A/en unknown
- 2021-10-05 MX MX2023003771A patent/MX2023003771A/es unknown
- 2021-10-05 EP EP21878327.2A patent/EP4225365A4/en active Pending
- 2021-10-05 CA CA3197304A patent/CA3197304A1/en active Pending
- 2021-10-05 CN CN202180081628.7A patent/CN117120086A/zh active Pending
- 2021-10-05 KR KR1020237014431A patent/KR20230155419A/ko active Pending
- 2021-10-05 US US18/030,426 patent/US20250277793A1/en active Pending
- 2021-10-05 AU AU2021357695A patent/AU2021357695A1/en active Pending
- 2021-10-05 JP JP2023521107A patent/JP2023553247A/ja active Pending